Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/44599
Title: Association of Tryptophan Metabolites with Incident Type 2 Diabetes in the PREDIMED Trial: A Case-Cohort Study
Authors: Yu, Edward
Papandreou, Christopher
Ruiz-Canela, Miguel
Guasch-Ferre, Marta
Clish, Clary B.
Dennis, Courtney
Liang, Liming
Corella, Dolores
Fitó, Montserrat
Razquin, Cristina
Lapetra, José
Estruch, Ramón
Ros, Emilio
Cofán, Montserrat
Arós, Fernando
Toledo, Estefania
Serra-Majem, Lluis 
Sorlí, José V.
Hu, Frank B.
Martinez-Gonzalez, Miguel A.
Salas-Salvado, Jordi
UNESCO Clasification: 2403 Bioquímica
2301 química analítica
Keywords: Diabetes
Insulin
Metabolites
Risk analysis
Cardiovascular disease
Issue Date: 2018
Publisher: 0009-9147
Journal: Clinical chemistry (Baltimore, Md.) 
Abstract: BACKGROUND: Metabolites of the tryptophan-kynurenine pathway (i.e., tryptophan, kynurenine, kynurenic acid, quinolinic acid, 3-hydroxyanthranilic) may be associated with diabetes development. Using a case-cohort design nested in the Prevencion con Dieta Mediterranea (PREDIMED) study, we studied the associations of baseline and 1-year changes of these metabolites with incident type 2 diabetes (T2D).
URI: http://hdl.handle.net/10553/44599
ISSN: 0009-9147
DOI: 10.1373/clinchem.2018.288720
Source: Clinical Chemistry [ISSN 0009-9147], v. 64 (8), p. 1211-1220
Appears in Collections:Artículos
Show full item record

SCOPUSTM   
Citations

16
checked on May 2, 2021

WEB OF SCIENCETM
Citations

17
checked on May 2, 2021

Page view(s)

15
checked on May 2, 2021

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.